An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
收藏DataCite Commons2025-09-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011666/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the long-term safety and efficacy of repeated subcutaneous (SC) administration of lanadelumab in adolescents and adults with non-histaminergic angioedema with normal C1-inhibitor who completed study SHP643-303 (NCT04206605).
提供机构：
Vivli
创建时间：
2025-07-30
